CANTOR FITZGERALD & CO.
NEW YORK, NY · CIK 17018 · 13F filing filed 2026-08-14
- Legal entityCANTOR FITZGERALD & CO. (US)
- Others nearbyNew York, NY
As an employer
US visa salary filings
- Filings FY2024–202514
- Median salary offered$105,000
- Middle half$100,000 – $128,750
- Job titles8
| Job title | Filings | Median |
|---|---|---|
| Analyst, Investment BankingNew York, NY | 5 | $105,000 |
| Analyst, Technology Investment BankingNew York, NY | 3 | $100,000 |
| Director, Senior Biotech AnalystNew York, NY | 1 | $275,000 |
| Associate, HealthcareNew York, NY | 1 | $175,000 |
| Investment Banking AnalystNew York, NY | 1 | $110,000 |
| Analyst, FinanceNew York, NY | 1 | $105,000 |
| Analyst, SalesNew York, NY | 1 | $100,000 |
| Analyst, PowerNew York, NY | 1 | $100,000 |
Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Cantor Fitzgerald & Co, Cantor Fitzgerald & Co..
For Q2 2026 this manager filed a 13F notice: its holdings were reported by another manager.
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| M3BRIGADE ACQUISITION V CORP VLOS · 13D · filed 2026-03-02 | 27.1%≈ $84.3m |
| SONO GROUP N V SEV1USD · 13G · filed 2026-02-13 | 7.0% |
| ONKURE THERAPEUTICS INC OKUR · 13G · filed 2025-08-14 | 5.2%≈ $3.1m |